NOT KNOWN FACTUAL STATEMENTS ABOUT HEMGENIX

Variety of qualified sufferers: CDEC talked about the uncertainty in the quantity of clients with reasonably significant to significant hemophilia B in Canada qualified for etranacogene dezaparvovec. Medical professionals consulted by CADTH indicated that some individuals who are classified as having moderate or reasonable ailment could have a extr